You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • SAT0094 Celecoxib does not increase the risk of cardiac failure, oedema, or hypertension compared to nsaids: results from success 1, a double blind, randomised trial in 13,274 oa patients

Citation Tools

Article menu
Download PDFPDF
Speaker abstracts 2001
Osteoarthritis – Clinical aspects and treatment
SAT0094 Celecoxib does not increase the risk of cardiac failure, oedema, or hypertension compared to nsaids: results from success 1, a double blind, randomised trial in 13,274 oa patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Whelton A, Singh G, White W, et al
SAT0094 Celecoxib does not increase the risk of cardiac failure, oedema, or hypertension compared to nsaids: results from success 1, a double blind, randomised trial in 13,274 oa patients
Annals of the Rheumatic Diseases 2001;60:A186.